Nonclinical aspects of biopharmaceutical development: discussion of case studies at a PhRMA-FDA workshop.
Buckley LA, Benson K, Davis-Bruno K, Dempster M, Finch GL, Harlow P, Haggerty HG, Hart T, Kinter L, Leighton JK, McNulty J, Roskos L, Saber H, Stauber A, Tabrizi M.
Buckley LA, et al. Among authors: stauber a.
Int J Toxicol. 2008 Jul-Aug;27(4):303-12. doi: 10.1080/10915810802367016.
Int J Toxicol. 2008.
PMID: 18821393